Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network

European Journal of Heart Failure

Volumn 11, Issue 3, 2009, Pages 229-237

  Otsuka, Kaoru ^a   Terasaki, Fumio ^a   Ikemoto, Masaki ^b   Fujita, Shuichi ^a   Tsukada, Bin ^a   Katashima, Takashi ^a   Kanzaki, Yumiko ^a   Sohmiya, Koichi ^a   Kono, Tatsuji ^a   Toko, Haruhiro ^c   Fujita, Masatoshi ^b   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Autoimmune myocarditis; Cytokines; Inflammation; S100A8 A9

Indexed keywords

CALGRANULIN A; CALGRANULIN B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; MODULATION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; GENETICS; LEWIS RAT; METABOLISM; TREATMENT OUTCOME;

ANIMALS; AUTOIMMUNE DISEASES; CALGRANULIN A; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MACROPHAGES; MALE; MYOCARDITIS; MYOCARDIUM; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; RNA, MESSENGER; TREATMENT OUTCOME;

EID: 65549141306     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfn049     Document Type: Article

References (30)

1. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998;1448:200-211.
2. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-9502.
3. Odink K, Cerletti N, Brüggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80-82.
4. Teigelkamp S, Bhardwaj RS, Roth J, Meinardus-Hager G, Karas M, Sorg C. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem 1991;266:13462-13467.
5. Frosch M, Vogl T, Seeliger S, Wulffraat N, Kuis W, Viemann D, Foell D, Sorg C, Sunderkötter C, Roth J. Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 2003;48:2622-2626.
6. Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin Chem 2003;49:594-600.
7. Terasaki F, Fujita M, Shimomura H, Tsukada B, Otsuka K, Otsuka K, Katashima T, Ikemoto M, Kitaura Y. Enhanced expression of myeloid related protein complex (MRP8/14) in macrophages and multinucleated giant cells in granulomas of patients with active cardiac sarcoidosis. Circ J 2007;71:1545-1550.
8. Ikemoto M, Murayama H, Itoh H, Totani M, Fujita M. Intrinsic function of S100A8/ 9 complex as an anti-inflammatory protein in liver injury induced by lipopolysac-charide in rats. Clin Chim Acta 2007;376:197-204.
9. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization, with cardiac myosin. Clin Immunol Immunopathol 1990;57:250-262.
10. Kamiyoshi Y, Takahashi M, Yokoseki O, Yazaki Y, Hirose S, Morimoto H, Watanabe N, Kinoshita O, Hongo M, Ikeda U. Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis. J Mol Cell Cardiol 2005;39:467-477.
11. Qing G, Ma LC, Khorchid A, Swapna GV, Mal TK, Takayama MM, Xia B, Phadtare S, Ke H, Acton T, Montelione GT, Ikura M, Inouye M. Cold-shock induced high-yield protein production in Escherichia coli. Nat Biotechnol 2004;22:877-882.
12. Matsui Y, Okamoto H,Jia N, Akino M, Uede T, Kitabatake A, NishihiraJ. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol 2004;37:557-566.
13. Suzuki J, Ogawa M, Futamatsu H, Kosuge H, Sagesaka YM, Isobe M. Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis. Eur J Heart Fail 2007;152-159.
14. Kodama M, Hanawa H, Zhang S, Saeki M, Koyama S, Hosono H, Miyakita Y, Katoh K, Inomata T, Izumi T, Shibata A. FK506 therapy of experimental autoimmune myocarditis after onset of the disease. Am Heart J 1993;126:1385- 1392.
15. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol 1997;29:491-502.
16. Eriksson U, Kurrer MO, Schmitz N, Marsch SC, Fontana A, Eugster HP, Kopf M. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 2003;107: 320-325.
17. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
18. Oppenheim JJ, Feldmann M. Introduction of the role of cytokines in innate host defense and adaptive immunity. In: Oppenheim JJ, Feldmann M, Durum SK, Hirano T, Vilcek J, Nicola NA, eds. Cytokine Reference. San Diego: Academic Press 2001 pp 3-20.
19. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172.
20. Van Miert AS. Present concepts on the inflammatory modulators with special reference to cytokines. Vet Res Commun 2002;26:111-126.
21. Ginn-Pease ME, Whisler RL Redox signals and NF-kappa B activation in T cells. Free Radic Biol Med 1998;25:346-361.
22. Robinson MJ, Tessier P, Poulsom R, Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminogly-cans on endothelial cells. J Biol Chem 2002;277:3658-3665.
23. Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001;166:4678-4688.
24. Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, Doussiere J. The ara-chidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J 2005;19:467-469.
25. Sohnle PG, Hunter MJ, Hahn B, Chazin WJ. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis 2000;182:1272-1275.
26. Newton RA, Hogg N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 1998;160:1427- 1435.
27. Yui S, Nakatani Y, Mikami M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol Pharm Bull 2003;26:753-760.
28. Roth J, Vogl T, Sorg C, Sunderkötter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003;24:155-158.
29. Foell D, Frosch M, Sorg C, Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta 2004;344: 37-51.
30. Metcalf D, Di Rago L, Mifsud S, Hartley L, Alexander WS. The development of fatal myocarditis and polymyositis in mice heterozygous for IFN-gamma and lacking the SOCS-1 gene. Proc Natl Acad Sci USA 2000;97:9174-9179.